China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...

WTI steadies as rising tensions between the United States and Iran boost a supply disruption premium for crude prices. An Iranian drone incident and threats near a U.S.-flagged vessel in the Strait of ...

Compass Pathways said a White House executive order may speed FDA review of its psilocybin therapy COMP360 for treatment-resistant depression trials.